Current Status of the Institutional Review Boards in Korea: Constitution, Operation, and Policy for Protection of Human Research Participants

Journal of Korean Medical Science

Volumn 18, Issue 1, 2003, Pages 3-10

  Kim, Ock Joo ^d   Park, Byung Joo ^a,b,d   Sohn, Dong Ryul ^c   Lee, Seung Mi ^a,b   Shin, Sang Goo ^b,d  

^a Korea University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Soonchunhyang University College of Medicine   (South Korea)

^d Korean Assoc Institutional Rev B   (South Korea)

Author keywords

Ethics Committees, Chinical; Ethics Committees, Research; Ethics, Institutional; Ethics, Research; Human Experimentation

Indexed keywords

CLINICAL EXAMINATION; COMMUNITY; FEMALE; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; KOREA; MALE; MEDICAL RESEARCH; MEDICAL SOCIETY; REVIEW; RISK FACTOR; SEX RATIO; ARTICLE; CLINICAL TRIAL; EPIDEMIOLOGY; HOSPITAL MANAGEMENT; HUMAN EXPERIMENT; INFORMATION PROCESSING; LEGAL ASPECT; METHODOLOGY; POLICY; POLITICS; PROFESSIONAL STANDARD; STANDARD; STATISTICS;

APPOINTMENTS AND SCHEDULES; CLINICAL TRIALS; DATA COLLECTION; EPIDEMIOLOGIC STUDIES; ETHICS COMMITTEES, RESEARCH; FEMALE; HUMAN EXPERIMENTATION; HUMANS; KOREA; MALE; POLITICS; PUBLIC POLICY; RESEARCH DESIGN;

EID: 0141889619     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2003.18.1.3     Document Type: Review

References (12)

1. The World Medical Association. Declaration of Helsinki. Revised at 52nd WMA General Assembly, Edinburgh, Scotland, October 2000.
2. Shin SG. Current status of clinical trials and GCP in the Republic of Korea. Drug Inf J 1997; 31: 1079-87.
3. Shin SG. The current status of clinical trials in the Republic of Korea. Drug Inf J 1998; 32: S1217-22.
4. Howard L, Charles K, Shin SG. Changes in clinical trial practice and the working environment in the Korean pharmaceutical industry since the implementation of Good Clinical Practice. Drug Inf J 2001; 35: 203-10.
5. ICH Harmonized Tripartite Guideline: E6. Good Clinical Practice: Consolidated Guideline. May 1996.
6. Korean Ministry of Health and Welfare. Guidelines of Korean Good Clinical Practice Guidelines. January 2001.
7. World Health Organization. Operational guidelines for ethics committees that review biomedical research. Geneva: WHO, 2000.
8. Wood A, Grady C, Emanuel EJ. The crisis in human participants research: identifying the problems and proposing solutions. http://www. bioethics.gov/emanuelpaper.html
9. Office of the Inspector General, Department of Health and Human Services. The globalization of clinical trials: a growing challenge in protecting human subjects. September 2001. OE1-01-00-00190.
10. World Health Organization. Surveying and evaluating ethical review practices, a companion guideline to the TDR WHO operational guidelines for ethics committees that review biomedical research (2000). Geneva: WHO, 2002.
11. European Forum for Good Clinical Practice. European guidelines for auditing independent ethics committees. Brussels: EFGCP, 2002.
12. European Network of GCP Auditors and Other GCP Experts. The ENGAGE guideline: optional guideline for good clinical practice compliance and quality systems auditing. Salve 1. Supplement to The EFGCP News, September 1998.